RNA Sequencing of H520 cells treated with ML355 or NVR and their controls treated with DMSO

We uncovered the retrotransposon L1-FGGY exhibited an oncogenic role via activating 12-LOX metabolic pathway in this study. In order to elucidate the underlying oncogenic roles of L1 and 12-LOX in tumorigenesis and tumor progression, we treated the H520 cells overexpressing L1-FGGY with NVR (reverse transcriptase inhibitor) and NVR (12-LOX inhibitor) and performed RNA sequencing for them.The results showed decrease of L1 level after treatment in both NVR and ML355, suggesting their potential effects on L1 suppress. Genes downregulated in NVR and ML355 treatment were enriched in cell cycle, cell growth and ATP metabolic process, which we showed to be related to LCT activity. Overall design: mRNA profiles of H520 cells overexpressing L1-FGGY treated with NVR (reverse transcriptase inhibitor) or NVR (12-LOX inhibitor) and their controls treated with DMSO